PFKP and triple-negative breast carcinoma: The results suggested that PFKP expression was significantly associated with the OS of triple-negative breast cancer patients, but there was no statistically difference in triple-negative breast cancer patients' RFS (P = 0.047, HR = 2.04, 95% CI 0.99–4.18 for OS, S4 Fig).